TECH BIO-TECHNE PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: TECH
- PE Ratio
As at May 13, 2025, the TECH stock has a PE ratio of 62.18. This is based on the current EPS of $0.83 and the stock price of $51.61 per share. A decrease of 15% has been seen in the P/E ratio compared to the average of 73.4 of the last 4 quarters.
TECH PE ratio history
The mean historical PE ratio of BIO-TECHNE over the last ten years is 57.36. The current 62.18 PE ratio is 8% above the historical average. Over the past ten years, TECH's PE ratio was at its highest in the Jun 2021 quarter at 123.7, with a price of $112.57 and an EPS of $0.91. The Sep 2015 quarter recorded the bottom point at 32.1, with a price of $23.12 and an EPS of $0.72.
BIO-TECHNE PE ratio by year
Maximum annual increase: 181.07% in 2021
Maximum annual decrease: -59.51% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 66.96 | 48.47% | $71.65 | $1.07 |
| 2023 | 45.1 | -9.96% | $81.63 | $1.81 |
| 2022 | 50.09 | -59.51% | $86.66 | $1.73 |
| 2021 | 123.7 | 181.07% | $112.57 | $0.91 |
| 2020 | 44.01 | -45.96% | $66.02 | $1.5 |
| 2019 | 81.44 | 84.96% | $52.12 | $0.64 |
| 2018 | 44.03 | -23.56% | $36.99 | $0.84 |
| 2017 | 57.6 | 43.03% | $29.38 | $0.51 |
| 2016 | 40.27 | 19.42% | $28.19 | $0.7 |
| 2015 | 33.72 | 9.27% | $24.62 | $0.73 |
| 2014 | 30.86 | 37.58% | $23.14 | $0.75 |
| 2013 | 22.43 | -8.11% | $17.27 | $0.77 |
| 2012 | 24.41 | -11.01% | $18.55 | $0.76 |
| 2011 | 27.43 | 41.32% | $20.84 | $0.76 |
| 2010 | 19.41 | -14.83% | $14.36 | $0.74 |
BIO-TECHNE PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 70.64 | -1.93% | $58.63 | $0.83 |
| Dec 2024 | 72.03 | -14.39% | $72.03 | $1 |
| Sep 2024 | 84.14 | 25.66% | $79.93 | $0.95 |
| Jun 2024 | 66.96 | 20.8% | $71.65 | $1.07 |
| Mar 2024 | 55.43 | 1.3% | $70.39 | $1.27 |
| Dec 2023 | 54.72 | 25.42% | $77.16 | $1.41 |
| Sep 2023 | 43.63 | -3.26% | $68.07 | $1.56 |
| Jun 2023 | 45.1 | 5.18% | $81.63 | $1.81 |
| Mar 2023 | 42.88 | -13.6% | $74.19 | $1.73 |
| Dec 2022 | 49.63 | 30.02% | $82.88 | $1.67 |
| Sep 2022 | 38.17 | -23.8% | $71 | $1.86 |
| Jun 2022 | 50.09 | -32.91% | $86.66 | $1.73 |
| Mar 2022 | 74.66 | -22.07% | $108.26 | $1.45 |
| Dec 2021 | 95.8 | -9.84% | $129.34 | $1.35 |
| Sep 2021 | 106.26 | -14.1% | $121.14 | $1.14 |
TECH Price vs fair value
TECH average PE ratio chart
The current PE ratio of TECH is greater than its 3 and 10-year historical averages, but it is below the 5-year average.
TECH PE vs peers
TECH's PE ratio is lower than its peer stock QGEN, but it is greater than GE's and TMO's. BIO-TECHNE is presently trading at a higher PE ratio (62.18) than its peer group average of 32.76.
| Stock name | PE ratio | Market cap |
|---|---|---|
| TMO Thermo Fisher Scientific Inc | 23.88 | $154.03B |
| BDX Becton Dickinson & Co | 33.02 | $49.02B |
| GE General Electric Co | 34.45 | $238.03B |
| DHR Danaher Corp | 36.17 | $134.36B |
| TECH BIO-TECHNE Corp | 57.63 | $7.5B |
| QGEN Qiagen NV | 95.72 | $8.96B |
| BIO Bio-Rad Laboratories Inc | N/A | $6.45B |
| STEM Stem Inc | N/A | $92.7M |
Frequently asked questions
What is BIO-TECHNE's PE ratio?
The price to earnings ratio for TECH stock as of May 13, 2025, stands at 62.18.
What is the 3-year average PE ratio for BIO-TECHNE (TECH)?
Over the last 3 years, the average price to earnings ratio for TECH stock is 56.12.
What is the 5-year average PE ratio for BIO-TECHNE (TECH)?
Over the last 5 years, the average price to earnings ratio for TECH stock is 65.26.
What is the highest PE ratio for TECH?
In the last ten years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 123.7.
How does the current PE ratio for TECH compare to its historical average?
TECH's current price to earnings ratio is 8% above its 10-year historical average.
How is TECH's PE ratio calculated (BIO-TECHNE PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 13, 2025), BIO-TECHNE's stock price is $51.61. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.83. Therefore, BIO-TECHNE's P/E ratio for today is 62.18. PE RATIO(62.18) = STOCK PRICE($51.61) / TTM EPS($0.83)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.